If you are a student, recent graduate or alumni interested in exploring a career in the biotechnology, pharmaceutical and life sciences industries, you are in the right place! Register today to start your job search and be contacted by employers nationwide looking for you! It only takes a few minutes and you will be on your way to the perfect job!
Thursday, February 18, 2010
The University of Colorado has applied for multi-million dollar federal grants to help finish the construction of its biotechnology building since the cash-strapped state is rejecting the school’s funding requests.
CU’s Boulder campus split the building’s construction into two projects so that it could move forward on construction, without depending on state funding. The first phase of the building will be 257,000 square feet, and CU expects it to be finished in fall 2011. The school has plans for a 54,000-square-foot addition, which hinges on funding.
Instead of waiting for an economic turn-around at the state level—which could leave construction on the final wing of the building stalled for an indefinite period of time—CU is looking for money elsewhere.Read Full Article
Monday, November 23, 2009
Our bodies make antibodies to fight off disease and bacteria, but this week’s Colorado Company to Watch has found a lot of financial success making them for researchers.
Advertisement
Novus Biological creates antibodies for scientists at universities, hospitals and the National Institutes of health. Their products are used by scientists who are looking for cures for cancer and hypoxia, as well as neuroscience research.
All told, the company creates, labels and distributes more than 100,000 different types of antibodies from it’s facility in Littleton.Read Full Article
Saturday, November 21, 2009
The Colorado BioScience Association (CBSA) has released the winners of its 2009
Awards Program. The announcement is made by John Collar, CBSA President and CEO,
who says the CBSA awards program showcases and honors those individuals and
companies making a significant difference to Colorado`s vibrant bioscience
industry this year.
Official presentation of the awards occurs Tuesday, November 10, 6:00 to 8:30
p.m., at the Denver Grand-Hyatt, 1750 Welton. Held in conjunction with the 2009
BioWest Conference & Expo, registration information is available at
http://www.BioWestConference.com. BioWest is the region`s preferred venue for
meeting investors, entrepreneurs, researchers, students, teachers and key
industry vendors.Read Full Article
Monday, October 19, 2009
Axial Biotech (Salt Lake City, Utah) developed the ScoliScore test that predicts whether children diagnosed with Adolescent Idiopathic Scoliosis (AIS) are likely to progress to severe disease. Of the children that present as at-risk (spine curvature >10%) less than 2% progress to the point where surgery is necessary (>40%), but all at-risk patients receive multiple x-rays resulting in extra costs and radiation exposure. The ScoliScore test is saliva-based and predicts the likelihood of progression based on multiple genetic markers.Read Full Article
posted in: Colorado , News, Utah
Sunday, October 18, 2009
In the world of biotech, the assumption is that the two poles of greatest and best activity center around San Francisco on the West Coast and Boston on the East Coast. This assumption is based on the historic role each city has played over the last 30+ years and the wealth of intellectual capital in the key research-based universities such as University of California - San Francisco and Stanford University in San Francisco and MIT and Harvard in Boston (just to name a few). It doesn’t hurt that a large concentration of venture capital is located in each city/region.Read Full Article
Monday, October 12, 2009
For three days, representatives from the Colorado BioScience Association
(CBSA),Colorado Office of Economic Development and International Trade, Metro
Denver Economic Development Corporation and the Greater Colorado Springs
Economic Development Corporation will be showcasing Colorado`s medical device
and diagnostics sectors during the annual AdvaMed: The MedTech Conference. The
announcement is made by John Collar, CBSA Executive Director, who says more than
1,400 industry leaders - including 500+ CEOs, Presidents and C-level executives
will be attending the AdvaMed: The MedTech Conference, October 12-14.
“This will be the CBSA`s third year participating in the AdvaMed Conference and
each year the potential connections and opportunity to showcase Colorado`s
medical device and diagnostics industries becomes even more abundant,” said
Collar. “According to our new state of the industry report, the Denver Metro
region ranks 19th among all U.S. metro areas in the size of our medical device
sector, and Boulder, Colorado ranks first in the nation in its concentration of
employment in the medical device sector among medium-sized metros. Colorado is
positioned as a leader in this sector and this conference provides us an
opportunity to promote the state.“Read Full Article
posted in: Colorado , News, Washington DC
Sunday, October 11, 2009
A small Boulder-based biotech company working with RANi therapeutics has sold some of its intellectual property to a larger Massachusetts firm.
Boulder-based Advirna LLC sold its technology, which can potentially enable in vivo delivery of RNAi therapeutics, to RXi Pharmaceuticals Corp. (Nasdaq: RXII) for an undisclosed amount.
RNAi-based therapeutics are being studied as a way to selectively silence gene transcriptions that lead to genetic diseases.Read Full Article
posted in: Colorado , Massachusetts, News
Saturday, October 10, 2009
Famuer Rasmussen Jr. and five other farmers filed what they thought was a routine request to grow genetically modified sugar beets on public land in Colorado’s Boulder County. The county already had allowed genetically altered corn.
But the farmers got an earful.
Complaints from residents and organic food activists concerned about the crops’ safety and local businesses hoping to maintain Boulder as a center for natural and organic products prompted county commissioners to reassess their genetically modified crops policy.Read Full Article
Thursday, September 24, 2009
Colorado Gov. Bill Ritter, University of Colorado President Bruce Benson, Nobel Laureate and CU Distinguished Professor Tom Cech, CU-Boulder Chancellor Philip DiStefano and members from the entire CU-Boulder community will gather Wednesday, Sept. 9, at 4:15 p.m. on the CU-Boulder East Campus to celebrate the groundbreaking of the Jennie Smoly Caruthers Biotechnology Building.
The state-of-the-art research and teaching facility will greatly enhance science and engineering education and discovery at CU, and bolster Colorado’s position in the nation’s biotechnology economy. The first phase of the building, comprising 257,000 square feet, is slated for completion in fall 2011, with plans for a 54,000-square-foot addition at a later date.Read Full Article
Saturday, September 19, 2009
Bolder BioTechnology, Inc. today
announced that it has been awarded two Phase I Small Business Innovation
Research (SBIR) grants totaling $1.2 million from the National Institute of
Allergy and Infectious Diseases (NIAID) of The National Institutes of Health
(NIH). The grants will be used to perform additional preclinical toxicology
and pharmacology studies of the company’s proprietary long-acting G-CSF and
GM-CSF analogs. Receipt of the entire grant award is contingent upon the
achievement of certain research milestones.
George (Joe) Cox, Ph.D., Company President and Principal Investigator for the
grants, said, “We are delighted to receive these grant awards from NIAID to
conduct research in Acute Radiation Syndrome (ARS). Through prior research
grants from the National Cancer Institute (NCI) we were able to demonstrate
that our modified G-CSF and GM-CSF analogs were very effective at accelerating
white blood cell recovery in chemotherapy-treated rats. We hope to show
similar beneficial effects of our proteins for treating ARS.“Read Full Article
Phoenix • Tucson • Palm Springs • Sacramento • San Diego • San Francisco • San Jose • Denver • Jacksonville • Miami • Orlando • Tampa • Atlanta • Chicago • Indianapolis • Kansas City • Louisville • New Orleans • Boston • Baltimore • Detroit • Grand Rapids • Minneapolis • Charlotte • Raleigh • Omaha • Atlantic City • Las Vegas • Reno • Buffalo • New York City • Cincinnati • Cleveland • Toledo • Tulsa • Portland • Philadelphia • Pittsburgh • Myrtle Beach • Memphis • Nashville • Austin • Dallas • Houston • San Antonio • Salt Lake City • Richmond • Seattle • Spokane
